This is Archived Content

This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA).
View current meetings on


November 10, 2013 - 12:00am
Philadelphia, Pennsylvania


2013 Meeting Overview:

From START to Finish: National and International Perspectives on Dissemination Research to Practice for the Treatment of Opioid Dependence, was a half-day preconference session held on November 10, 2013. Dr. Andrew J. Saxon chaired the session and presented on the study which utilized START’s database of patients (n=1269). This was followed by 2 panels; the first provided the United States perspective and the multitude of interesting and clinically relevant secondary outcomes from the START study and the resulting dissemination strategies. The second panel explored the international perspective by examining studies conducted aboard and successful treatment strategies.  

Goals and Objectives:

The goal of the meeting was to provide participants with information on successful national and international dissemination strategies for patients in opioid agonist treatment programs that could be used in clinical settings.  

At the end of the session, attendees were able to:

  • Use evidence-based approaches in the implementation of relevant MET or BUP/Nx treatment in clinical settings both nationally and internationally 


There were approximately 75 people in attendance for this session.


Begin Session Faculty
8:30 a.m. Session opens
  Session Opening Remarks
Starting Treatment with Agonist Replacement Treatment Study (START)
Session Chair:
Andrew J. Saxon, M.D.
  United States Perspective:
Secondary outcomes of START study
  • MET vs. BUP/Nx on HIV risk behaviors
  • 6 BUP/Nx and 3 MET induction trajectories
  • Genotype and treatment outcome associations in African-American participants
George Woody, M.D.
Petra Jacobs, M.D.
Richard Crist, PhD.
  International Perspective:
  • NIDA and Indonesia
  • MET treatment and mortality rates
  • Incentive-based interventions
Adhi Wibowo Nurhidayat, M.D.
Mathew Hickman, PhD.
John Stran, M.D.,
  Discussion Led by:
Andrew J. Saxon, M.D.
12:30 PM Adjourn